Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-LIPE Polyclonal Antibody

Catalog #:   PHG04801 Specific References (97) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: Q05469
Overview

Catalog No.

PHG04801

Species reactivity

Human, Mouse

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human LIPE (Met302-Leu425).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Monoacylglycerol lipase LIPE, LIPE, HSL, Retinyl ester hydrolase, REH, Hormone-sensitive lipase

Purification

Purified by antigen affinity column.

Accession

Q05469

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with LIPE antibody (PHG04801) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 16 kDa
    Observed MW: 16 kDa
References

The clock component LHY1b negatively regulates alkaline stress by repressing AOX1-mediated oxidative responses in soybean., PMID:40513111

The clock component LHY1b negatively regulates alkaline stress by repressing AOX1-mediated oxidative responses in soybean., PMID:40513111

PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance., PMID:40512837

PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance., PMID:40512837

IL-33 Has a Protective Effect Against Perinatal Listeriosis by Regulating Mitophagy of CD8+ T Lymphocytes., PMID:40512525

Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma., PMID:40512454

Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma., PMID:40512454

Mechanistic investigation of calcium phosphate mineralization potentiating the cellular immune response of foot-and-mouth disease virus-like particle vaccines., PMID:40512119

Mechanistic investigation of calcium phosphate mineralization potentiating the cellular immune response of foot-and-mouth disease virus-like particle vaccines., PMID:40512119

The impact of anti-M antibodies on patient blood typing and transfusion safety: a retrospective study., PMID:40512094

The impact of anti-M antibodies on patient blood typing and transfusion safety: a retrospective study., PMID:40512094

Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer., PMID:40511831

Key indicators for guiding tocilizumab therapy to prevent orbital decompression surgery in hormone-resistant dysthyroid optic neuropathy., PMID:40510358

Key indicators for guiding tocilizumab therapy to prevent orbital decompression surgery in hormone-resistant dysthyroid optic neuropathy., PMID:40510358

[Predictors of adverse pregnancy outcomes in patients with systemic lupus erythematosus]., PMID:40509840

[Predictors of adverse pregnancy outcomes in patients with systemic lupus erythematosus]., PMID:40509840

Screening and Analysis of the Clinical Characteristics of Celiac Disease Autoimmunity in the Young Population in Northwest China., PMID:40509574

Screening and Analysis of the Clinical Characteristics of Celiac Disease Autoimmunity in the Young Population in Northwest China., PMID:40509574

Purification of Prudu6 from Almond and Its Cross-Reactivity with Glym6 from Soybean., PMID:40508232

Purification of Prudu6 from Almond and Its Cross-Reactivity with Glym6 from Soybean., PMID:40508232

Unraveling Botulinum Neurotoxin A Light-Chain-Induced Signaling Pathways: A Phosphoproteomic Analysis in a Controlled Cellular Model., PMID:40507977

Unraveling Botulinum Neurotoxin A Light-Chain-Induced Signaling Pathways: A Phosphoproteomic Analysis in a Controlled Cellular Model., PMID:40507977

Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies., PMID:40507880

Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies., PMID:40507880

Mechanistic Insights into Anti-Nectin4-VcMMAE-Induced Ocular Toxicity: From Cellular Uptake Pathways to Molecular Modification., PMID:40507807

Mechanistic Insights into Anti-Nectin4-VcMMAE-Induced Ocular Toxicity: From Cellular Uptake Pathways to Molecular Modification., PMID:40507807

Rapid detection of SARS-CoV-2 antigen based on IgG colloidal gold immunochromatographic strip., PMID:40506633

Rapid detection of SARS-CoV-2 antigen based on IgG colloidal gold immunochromatographic strip., PMID:40506633

Epidemiological insights and clinical management of paediatric kala-azar in Shanxi Province (2014-2023): retrospective analysis of case characteristics and therapeutic strategies., PMID:40506085

Epidemiological insights and clinical management of paediatric kala-azar in Shanxi Province (2014-2023): retrospective analysis of case characteristics and therapeutic strategies., PMID:40506085

Oral Administration of Hydrolyzed Egg Yolk Peptides With Low Molecular Weight Increased Bone Density by Regulating Bone Metabolism and Immune Responses., PMID:40504632

Oral Administration of Hydrolyzed Egg Yolk Peptides With Low Molecular Weight Increased Bone Density by Regulating Bone Metabolism and Immune Responses., PMID:40504632

Clinical and prognostic profiles in immune-mediated hypertrophic meningitis: a retrospective analysis of 92 cases., PMID:40504382

Clinical and prognostic profiles in immune-mediated hypertrophic meningitis: a retrospective analysis of 92 cases., PMID:40504382

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Profiles of a Single-Dose JYB1904 in Healthy Chinese Participants: A Phase Ia, Randomized, Double-Blind, Placebo-Controlled Study., PMID:40504164

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Profiles of a Single-Dose JYB1904 in Healthy Chinese Participants: A Phase Ia, Randomized, Double-Blind, Placebo-Controlled Study., PMID:40504164

Analysis of Treatment and Subsequent Pregnancy Outcomes in Patients With Antinuclear Antibody-Positive Recurrent Spontaneous Abortion., PMID:40504075

Analysis of Treatment and Subsequent Pregnancy Outcomes in Patients With Antinuclear Antibody-Positive Recurrent Spontaneous Abortion., PMID:40504075

Global clinical trial landscape and therapeutic trends in bladder cancer: a systematic analysis., PMID:40503775

Global clinical trial landscape and therapeutic trends in bladder cancer: a systematic analysis., PMID:40503775

Structural and Functional Characterization of Disulfide Bond Isomers of Therapeutic Immunoglobulin G2 Antibody., PMID:40503755

Structural and Functional Characterization of Disulfide Bond Isomers of Therapeutic Immunoglobulin G2 Antibody., PMID:40503755

Cerebral Hemorrhage-Related Inflammatory Response Mediated by NINJ1 and the Protective Effects of Atorvastatin., PMID:40503750

Cerebral Hemorrhage-Related Inflammatory Response Mediated by NINJ1 and the Protective Effects of Atorvastatin., PMID:40503750

Priming or Boosting P. falciparum Transmission Blocking Responses with Recombinant Vaccines or Gametocyte Extract., PMID:40503613

Priming or Boosting P. falciparum Transmission Blocking Responses with Recombinant Vaccines or Gametocyte Extract., PMID:40503613

Baseline type 2 biomarker levels and clinical remission predictors in children with asthma., PMID:40503233

Baseline type 2 biomarker levels and clinical remission predictors in children with asthma., PMID:40503233

Identification and Pathogenicity Analysis of Feline Calicivirus in Shanghai and Guangdong, China., PMID:40503218

Identification and Pathogenicity Analysis of Feline Calicivirus in Shanghai and Guangdong, China., PMID:40503218

Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodies., PMID:40502578

Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodies., PMID:40502578

Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV-1 V2 apex broadly neutralizing antibody development., PMID:40502159

Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV-1 V2 apex broadly neutralizing antibody development., PMID:40502159

Sez6L2 autoimmunity induces cerebellar ataxia in mice., PMID:40502079

Sez6L2 autoimmunity induces cerebellar ataxia in mice., PMID:40502079

HIV-1 envelopes from virions that persist in plasma on antiretroviral therapy show reduced susceptibility to autologous immunoglobulins and variable sensitivity to broadly neutralizing monoclonal antibodies., PMID:40502069

HIV-1 envelopes from virions that persist in plasma on antiretroviral therapy show reduced susceptibility to autologous immunoglobulins and variable sensitivity to broadly neutralizing monoclonal antibodies., PMID:40502069

Robust Serum Proteomic Signatures of APOE2., PMID:40501769

Robust Serum Proteomic Signatures of APOE2., PMID:40501769

TAP1 promotes immune escape by activating JNK/STAT1/PD-L1 signaling in EBV-associated gastric cancer., PMID:40500531

TAP1 promotes immune escape by activating JNK/STAT1/PD-L1 signaling in EBV-associated gastric cancer., PMID:40500531

Topical delivery of a human single-domain antibody targeting IL-33 to inhibit mucosal inflammation., PMID:40500403

Topical delivery of a human single-domain antibody targeting IL-33 to inhibit mucosal inflammation., PMID:40500403

Mechanistic insights into Schisandrin C as the active anti-renal fibrosis ingredient of Schisandra chinensis: a network pharmacology analysis and transcriptomics integrated experimental verification., PMID:40500382

Mechanistic insights into Schisandrin C as the active anti-renal fibrosis ingredient of Schisandra chinensis: a network pharmacology analysis and transcriptomics integrated experimental verification., PMID:40500382

Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicity., PMID:40500295

Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicity., PMID:40500295

QSP modeling of loncastuximab tesirine with T-cell-dependent bispecific antibodies guides dose-regimen strategy., PMID:40500294

QSP modeling of loncastuximab tesirine with T-cell-dependent bispecific antibodies guides dose-regimen strategy., PMID:40500294

Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C., PMID:40499720

Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C., PMID:40499720

Preclinical evaluation of DB-1419, a novel bifunctional and bispecific anti-B7-H3×PD-L1 antibody-drug conjugate., PMID:40499141

Preclinical evaluation of DB-1419, a novel bifunctional and bispecific anti-B7-H3×PD-L1 antibody-drug conjugate., PMID:40499141

Codelivery of Anti-PD-L1 and Indocyanine Green by a β-Cyclodextrin-Based Nanogel Carrier System for Cancer-Targeted Photothermal and Immunotherapy., PMID:40499082

Codelivery of Anti-PD-L1 and Indocyanine Green by a β-Cyclodextrin-Based Nanogel Carrier System for Cancer-Targeted Photothermal and Immunotherapy., PMID:40499082

Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates., PMID:40498855

Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates., PMID:40498855

Extracellular HSP90-Facilitated Degradation of Extracellular and Membrane Proteins by Bifunctional Small Molecules., PMID:40497783

Extracellular HSP90-Facilitated Degradation of Extracellular and Membrane Proteins by Bifunctional Small Molecules., PMID:40497783

Ocular Hypertension or Glaucoma Risk Factor Prediction Models for Patients with Fuchs Uveitis Syndrome., PMID:40497633

Ocular Hypertension or Glaucoma Risk Factor Prediction Models for Patients with Fuchs Uveitis Syndrome., PMID:40497633

PARP inhibitors accumulate B7-H3 on fibroblasts via blocking autophagic flux to potentiate immune evasion in ovarian cancer., PMID:40497528

PARP inhibitors accumulate B7-H3 on fibroblasts via blocking autophagic flux to potentiate immune evasion in ovarian cancer., PMID:40497528

Detection of Urinary SERPINA4 by Electrochemiluminescence Immunoassay and Development of a Diagnostic Model for Diabetic Nephropathy., PMID:40497287

Detection of Urinary SERPINA4 by Electrochemiluminescence Immunoassay and Development of a Diagnostic Model for Diabetic Nephropathy., PMID:40497287

Case Report: Robust and durable response to the combination of tislelizumab and chemotherapy in advanced thymic epithelial tumors: a case series., PMID:40496871

Case Report: Robust and durable response to the combination of tislelizumab and chemotherapy in advanced thymic epithelial tumors: a case series., PMID:40496871

Anti-RPL30 as a novel biomarker for enhanced diagnosis of autoantibody-negative primary biliary cholangitis., PMID:40495948

Anti-RPL30 as a novel biomarker for enhanced diagnosis of autoantibody-negative primary biliary cholangitis., PMID:40495948

Online Coupling of Asymmetrical Flow Field-Flow Fractionation with Native Mass Spectrometry for Monoclonal Antibody Characterization., PMID:40495648

IL16 Promotes Plasma Cell Differentiation., PMID:40495388

IL16 Promotes Plasma Cell Differentiation., PMID:40495388

Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy., PMID:40495114

Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy., PMID:40495114

Breadth of influenza A antibody cross-reactivity varies by virus isolation interval and subtype., PMID:40494885

Breadth of influenza A antibody cross-reactivity varies by virus isolation interval and subtype., PMID:40494885

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-LIPE Polyclonal Antibody [PHG04801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only